Results 171 to 180 of about 44,865 (239)

A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701). [PDF]

open access: yesESMO Open
Masuishi T   +28 more
europepmc   +1 more source

Prognostic significance of BRAF V600E and TERT promoter mutations in radioiodine resistance and recurrence of differentiated thyroid cancer. [PDF]

open access: yesMedicine (Baltimore)
Nhung LTT   +9 more
europepmc   +1 more source

Successful Treatment of BRAF V600E-Mutant Intrahepatic Cholangiocarcinoma With Encorafenib, Binimetinib, and Cetuximab. [PDF]

open access: yesCureus
Yamaguchi T   +9 more
europepmc   +1 more source

Validation of preoperative BRAF V600E testing by ThyroSCAN PanelChip in thyroid nodules. [PDF]

open access: yesEndocr Connect
Lee PS   +8 more
europepmc   +1 more source

Association Between <i>BRAF V600E</i> Allele Frequency and Aggressive Behavior in Papillary Thyroid Microcarcinoma. [PDF]

open access: yesCancers (Basel)
Tatar L   +7 more
europepmc   +1 more source

BRAF V600E-Mutant Diffuse Pulmonary Langerhans Cell Histiocytosis Successfully Treated With Dabrafenib Plus Trametinib: A Case Report. [PDF]

open access: yesRespirol Case Rep
Sakurai A   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy